Form 4: Amphastar Pharmaceuticals Director Floyd F. Petersen Sells 1,000 Shares

Director Floyd F. Petersen sold 1,000 shares of Amphastar Pharmaceuticals (AMPH) common stock at an average price of $27.9863 on March 6, 2025, according to a Form 4 filing.

Summary

• On March 6, 2025, Floyd F. Petersen, a director of Amphastar Pharmaceuticals, Inc. (AMPH), sold 1,000 shares of common stock.
• The sale was executed at a weighted average price of $27.9863 per share, with individual transactions ranging from $27.66 to $28.295.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024.
• Following the reported transaction, Petersen directly owns 74,409 shares of Amphastar Pharmaceuticals.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a routine disclosure of a stock sale under a pre-arranged trading plan, and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This transaction is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders regarding the stock's valuation and future prospects. However, a single sale under a pre-arranged trading plan may not be indicative of a broader trend.

Stakeholder Impact

• The sale of shares by a director could have a minor psychological impact on shareholders, but the effect is likely to be minimal given the relatively small number of shares sold and the existence of a pre-arranged trading plan.

Key Dates